Search

everythinglearnresearchcommunity

for

Search:↓

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Melatonin improved mental health and metabolism in women with PCOS.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Women with irregular periods have a higher risk of heart disease.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

PCOS may be influenced by factors in the blood, not just the ovaries.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.